Global Anticoagulants Market Research Report 2022
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anticoagulants Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Platelet Aggregation Inhibitors (PAI)
1.2.3 Low-Molecular-Weight Heparin (LMWH)
1.2.4 Direct Thrombin Inhibitor (DTI)
1.2.5 Direct Factor Xa Inhibitors (DFXa)
1.2.6 Vitamin K antagonists (VKA)
1.2.7 Others
1.3 Market by Application
1.3.1 Global Anticoagulants Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 VTE
1.3.3 ACS/MI
1.3.4 AF
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Anticoagulants Market Perspective (2017-2028)
2.2 Anticoagulants Growth Trends by Region
2.2.1 Anticoagulants Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Anticoagulants Historic Market Size by Region (2017-2022)
2.2.3 Anticoagulants Forecasted Market Size by Region (2023-2028)
2.3 Anticoagulants Market Dynamics
2.3.1 Anticoagulants Industry Trends
2.3.2 Anticoagulants Market Drivers
2.3.3 Anticoagulants Market Challenges
2.3.4 Anticoagulants Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anticoagulants Players by Revenue
3.1.1 Global Top Anticoagulants Players by Revenue (2017-2022)
3.1.2 Global Anticoagulants Revenue Market Share by Players (2017-2022)
3.2 Global Anticoagulants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Anticoagulants Revenue
3.4 Global Anticoagulants Market Concentration Ratio
3.4.1 Global Anticoagulants Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anticoagulants Revenue in 2021
3.5 Anticoagulants Key Players Head office and Area Served
3.6 Key Players Anticoagulants Product Solution and Service
3.7 Date of Enter into Anticoagulants Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Anticoagulants Breakdown Data by Type
4.1 Global Anticoagulants Historic Market Size by Type (2017-2022)
4.2 Global Anticoagulants Forecasted Market Size by Type (2023-2028)
5 Anticoagulants Breakdown Data by Application
5.1 Global Anticoagulants Historic Market Size by Application (2017-2022)
5.2 Global Anticoagulants Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Anticoagulants Market Size (2017-2028)
6.2 North America Anticoagulants Market Size by Country (2017-2022)
6.3 North America Anticoagulants Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Anticoagulants Market Size (2017-2028)
7.2 Europe Anticoagulants Market Size by Country (2017-2022)
7.3 Europe Anticoagulants Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anticoagulants Market Size (2017-2028)
8.2 Asia-Pacific Anticoagulants Market Size by Country (2017-2022)
8.3 Asia-Pacific Anticoagulants Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Anticoagulants Market Size (2017-2028)
9.2 Latin America Anticoagulants Market Size by Country (2017-2022)
9.3 Latin America Anticoagulants Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anticoagulants Market Size (2017-2028)
10.2 Middle East & Africa Anticoagulants Market Size by Country (2017-2022)
10.3 Middle East & Africa Anticoagulants Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Anticoagulants Introduction
11.1.4 Sanofi Revenue in Anticoagulants Business (2017-2022)
11.1.5 Sanofi Recent Development
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Detail
11.2.2 Bristol-Myers Squibb Business Overview
11.2.3 Bristol-Myers Squibb Anticoagulants Introduction
11.2.4 Bristol-Myers Squibb Revenue in Anticoagulants Business (2017-2022)
11.2.5 Bristol-Myers Squibb Recent Development
11.3 Bayer
11.3.1 Bayer Company Detail
11.3.2 Bayer Business Overview
11.3.3 Bayer Anticoagulants Introduction
11.3.4 Bayer Revenue in Anticoagulants Business (2017-2022)
11.3.5 Bayer Recent Development
11.4 Johnson & Johnson.
11.4.1 Johnson & Johnson. Company Detail
11.4.2 Johnson & Johnson. Business Overview
11.4.3 Johnson & Johnson. Anticoagulants Introduction
11.4.4 Johnson & Johnson. Revenue in Anticoagulants Business (2017-2022)
11.4.5 Johnson & Johnson. Recent Development
11.5 Genentech (Roche)
11.5.1 Genentech (Roche) Company Detail
11.5.2 Genentech (Roche) Business Overview
11.5.3 Genentech (Roche) Anticoagulants Introduction
11.5.4 Genentech (Roche) Revenue in Anticoagulants Business (2017-2022)
11.5.5 Genentech (Roche) Recent Development
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Detail
11.6.2 Boehringer Ingelheim Business Overview
11.6.3 Boehringer Ingelheim Anticoagulants Introduction
11.6.4 Boehringer Ingelheim Revenue in Anticoagulants Business (2017-2022)
11.6.5 Boehringer Ingelheim Recent Development
11.7 Lilly
11.7.1 Lilly Company Detail
11.7.2 Lilly Business Overview
11.7.3 Lilly Anticoagulants Introduction
11.7.4 Lilly Revenue in Anticoagulants Business (2017-2022)
11.7.5 Lilly Recent Development
11.8 Daiichi Sankyo
11.8.1 Daiichi Sankyo Company Detail
11.8.2 Daiichi Sankyo Business Overview
11.8.3 Daiichi Sankyo Anticoagulants Introduction
11.8.4 Daiichi Sankyo Revenue in Anticoagulants Business (2017-2022)
11.8.5 Daiichi Sankyo Recent Development
11.9 Otsuka
11.9.1 Otsuka Company Detail
11.9.2 Otsuka Business Overview
11.9.3 Otsuka Anticoagulants Introduction
11.9.4 Otsuka Revenue in Anticoagulants Business (2017-2022)
11.9.5 Otsuka Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Detail
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca Anticoagulants Introduction
11.10.4 AstraZeneca Revenue in Anticoagulants Business (2017-2022)
11.10.5 AstraZeneca Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Detail
11.11.2 Pfizer Business Overview
11.11.3 Pfizer Anticoagulants Introduction
11.11.4 Pfizer Revenue in Anticoagulants Business (2017-2022)
11.11.5 Pfizer Recent Development
11.12 Aspen
11.12.1 Aspen Company Detail
11.12.2 Aspen Business Overview
11.12.3 Aspen Anticoagulants Introduction
11.12.4 Aspen Revenue in Anticoagulants Business (2017-2022)
11.12.5 Aspen Recent Development
11.13 The Medicines Company
11.13.1 The Medicines Company Company Detail
11.13.2 The Medicines Company Business Overview
11.13.3 The Medicines Company Anticoagulants Introduction
11.13.4 The Medicines Company Revenue in Anticoagulants Business (2017-2022)
11.13.5 The Medicines Company Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Anticoagulants Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Platelet Aggregation Inhibitors (PAI)
Table 3. Key Players of Low-Molecular-Weight Heparin (LMWH)
Table 4. Key Players of Direct Thrombin Inhibitor (DTI)
Table 5. Key Players of Direct Factor Xa Inhibitors (DFXa)
Table 6. Key Players of Vitamin K antagonists (VKA)
Table 7. Key Players of Others
Table 8. Global Anticoagulants Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 9. Global Anticoagulants Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 10. Global Anticoagulants Market Size by Region (2017-2022) & (US$ Million)
Table 11. Global Anticoagulants Market Share by Region (2017-2022)
Table 12. Global Anticoagulants Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 13. Global Anticoagulants Market Share by Region (2023-2028)
Table 14. Anticoagulants Market Trends
Table 15. Anticoagulants Market Drivers
Table 16. Anticoagulants Market Challenges
Table 17. Anticoagulants Market Restraints
Table 18. Global Anticoagulants Revenue by Players (2017-2022) & (US$ Million)
Table 19. Global Anticoagulants Market Share by Players (2017-2022)
Table 20. Global Top Anticoagulants Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anticoagulants as of 2021)
Table 21. Ranking of Global Top Anticoagulants Companies by Revenue (US$ Million) in 2021
Table 22. Global 5 Largest Players Market Share by Anticoagulants Revenue (CR5 and HHI) & (2017-2022)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Anticoagulants Product Solution and Service
Table 25. Date of Enter into Anticoagulants Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Anticoagulants Market Size by Type (2017-2022) & (US$ Million)
Table 28. Global Anticoagulants Revenue Market Share by Type (2017-2022)
Table 29. Global Anticoagulants Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 30. Global Anticoagulants Revenue Market Share by Type (2023-2028)
Table 31. Global Anticoagulants Market Size by Application (2017-2022) & (US$ Million)
Table 32. Global Anticoagulants Revenue Market Share by Application (2017-2022)
Table 33. Global Anticoagulants Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 34. Global Anticoagulants Revenue Market Share by Application (2023-2028)
Table 35. North America Anticoagulants Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Anticoagulants Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Anticoagulants Market Size by Country (2017-2022) & (US$ Million)
Table 38. Europe Anticoagulants Market Size by Country (2023-2028) & (US$ Million)
Table 39. Asia-Pacific Anticoagulants Market Size by Region (2017-2022) & (US$ Million)
Table 40. Asia-Pacific Anticoagulants Market Size by Region (2023-2028) & (US$ Million)
Table 41. Latin America Anticoagulants Market Size by Country (2017-2022) & (US$ Million)
Table 42. Latin America Anticoagulants Market Size by Country (2023-2028) & (US$ Million)
Table 43. Middle East & Africa Anticoagulants Market Size by Country (2017-2022) & (US$ Million)
Table 44. Middle East & Africa Anticoagulants Market Size by Country (2023-2028) & (US$ Million)
Table 45. Sanofi Company Detail
Table 46. Sanofi Business Overview
Table 47. Sanofi Anticoagulants Product
Table 48. Sanofi Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 49. Sanofi Recent Development
Table 50. Bristol-Myers Squibb Company Detail
Table 51. Bristol-Myers Squibb Business Overview
Table 52. Bristol-Myers Squibb Anticoagulants Product
Table 53. Bristol-Myers Squibb Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 54. Bristol-Myers Squibb Recent Development
Table 55. Bayer Company Detail
Table 56. Bayer Business Overview
Table 57. Bayer Anticoagulants Product
Table 58. Bayer Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 59. Bayer Recent Development
Table 60. Johnson & Johnson. Company Detail
Table 61. Johnson & Johnson. Business Overview
Table 62. Johnson & Johnson. Anticoagulants Product
Table 63. Johnson & Johnson. Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 64. Johnson & Johnson. Recent Development
Table 65. Genentech (Roche) Company Detail
Table 66. Genentech (Roche) Business Overview
Table 67. Genentech (Roche) Anticoagulants Product
Table 68. Genentech (Roche) Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 69. Genentech (Roche) Recent Development
Table 70. Boehringer Ingelheim Company Detail
Table 71. Boehringer Ingelheim Business Overview
Table 72. Boehringer Ingelheim Anticoagulants Product
Table 73. Boehringer Ingelheim Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 74. Boehringer Ingelheim Recent Development
Table 75. Lilly Company Detail
Table 76. Lilly Business Overview
Table 77. Lilly Anticoagulants Product
Table 78. Lilly Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 79. Lilly Recent Development
Table 80. Daiichi Sankyo Company Detail
Table 81. Daiichi Sankyo Business Overview
Table 82. Daiichi Sankyo Anticoagulants Product
Table 83. Daiichi Sankyo Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 84. Daiichi Sankyo Recent Development
Table 85. Otsuka Company Detail
Table 86. Otsuka Business Overview
Table 87. Otsuka Anticoagulants Product
Table 88. Otsuka Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 89. Otsuka Recent Development
Table 90. AstraZeneca Company Detail
Table 91. AstraZeneca Business Overview
Table 92. AstraZeneca Anticoagulants Product
Table 93. AstraZeneca Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 94. AstraZeneca Recent Development
Table 95. Pfizer Company Detail
Table 96. Pfizer Business Overview
Table 97. Pfizer AnticoagulantsProduct
Table 98. Pfizer Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 99. Pfizer Recent Development
Table 100. Aspen Company Detail
Table 101. Aspen Business Overview
Table 102. Aspen AnticoagulantsProduct
Table 103. Aspen Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 104. Aspen Recent Development
Table 105. The Medicines Company Company Detail
Table 106. The Medicines Company Business Overview
Table 107. The Medicines Company AnticoagulantsProduct
Table 108. The Medicines Company Revenue in Anticoagulants Business (2017-2022) & (US$ Million)
Table 109. The Medicines Company Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Anticoagulants Market Share by Type: 2021 VS 2028
Figure 2. Platelet Aggregation Inhibitors (PAI) Features
Figure 3. Low-Molecular-Weight Heparin (LMWH) Features
Figure 4. Direct Thrombin Inhibitor (DTI) Features
Figure 5. Direct Factor Xa Inhibitors (DFXa) Features
Figure 6. Vitamin K antagonists (VKA) Features
Figure 7. Others Features
Figure 8. Global Anticoagulants Market Share by Application in 2021 & 2028
Figure 9. VTE Case Studies
Figure 10. ACS/MI Case Studies
Figure 11. AF Case Studies
Figure 12. Others Case Studies
Figure 13. Anticoagulants Report Years Considered
Figure 14. Global Anticoagulants Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 15. Global Anticoagulants Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 16. Global Anticoagulants Market Share by Region: 2021 VS 2028
Figure 17. Global Anticoagulants Market Share by Players in 2021
Figure 18. Global Top Anticoagulants Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anticoagulants as of 2021)
Figure 19. The Top 10 and 5 Players Market Share by Anticoagulants Revenue in 2021
Figure 20. North America Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. North America Anticoagulants Market Share by Country (2017-2028)
Figure 22. United States Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Europe Anticoagulants Market Share by Country (2017-2028)
Figure 26. Germany Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. France Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. U.K. Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Italy Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Russia Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Nordic Countries Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Asia-Pacific Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Asia-Pacific Anticoagulants Market Share by Region (2017-2028)
Figure 34. China Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Japan Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. South Korea Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Southeast Asia Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. India Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Australia Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Latin America Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Latin America Anticoagulants Market Share by Country (2017-2028)
Figure 42. Mexico Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Brazil Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Middle East & Africa Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Middle East & Africa Anticoagulants Market Share by Country (2017-2028)
Figure 46. Turkey Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Saudi Arabia Anticoagulants Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 48. Sanofi Revenue Growth Rate in Anticoagulants Business (2017-2022)
Figure 49. Bristol-Myers Squibb Revenue Growth Rate in Anticoagulants Business (2017-2022)
Figure 50. Bayer Revenue Growth Rate in Anticoagulants Business (2017-2022)
Figure 51. Johnson & Johnson. Revenue Growth Rate in Anticoagulants Business (2017-2022)
Figure 52. Genentech (Roche) Revenue Growth Rate in Anticoagulants Business (2017-2022)
Figure 53. Boehringer Ingelheim Revenue Growth Rate in Anticoagulants Business (2017-2022)
Figure 54. Lilly Revenue Growth Rate in Anticoagulants Business (2017-2022)
Figure 55. Daiichi Sankyo Revenue Growth Rate in Anticoagulants Business (2017-2022)
Figure 56. Otsuka Revenue Growth Rate in Anticoagulants Business (2017-2022)
Figure 57. AstraZeneca Revenue Growth Rate in Anticoagulants Business (2017-2022)
Figure 58. Pfizer Revenue Growth Rate in Anticoagulants Business (2017-2022)
Figure 59. Aspen Revenue Growth Rate in Anticoagulants Business (2017-2022)
Figure 60. The Medicines Company Revenue Growth Rate in Anticoagulants Business (2017-2022)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed